News Headlines Article

Targeted breast cancer therapies hit forefront
Monterey Herald

If there ever was a right time to be diagnosed with breast cancer, Beth Thompson found one.

In February 2006, the pea-size tumor in her right breast was too small for a clinical trial of Herceptin, a targeted therapy that had proved effective in advanced stages of the aggressive cancer Thompson had. She underwent a lumpectomy and chemotherapy. When the cancer continued to show signs of growth, she had a double mastectomy.